These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8300945)

  • 1. High-dose tocopherol acetate therapy in epidermolysis bullosa siblings of the Cockayne-Touraine type.
    Shirakata Y; Shiraishi S; Sayama K; Shinmori H; Miki Y
    J Dermatol; 1993 Nov; 20(11):723-5. PubMed ID: 8300945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of epidermolysis bullosa hereditaria--dominant dystrophic type of Cockayne and Touraine.
    Yotsumoto S; Setoyama M; Hisadome H; Tashiro M; Murata F
    Dermatology; 1993; 186(3):201-4. PubMed ID: 8453148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis by electron microscopy of recessive dystrophic epidermolysis bullosa].
    Glorio RR; Solari A; Woscoff A
    Medicina (B Aires); 2000; 60(3):354-6. PubMed ID: 11050816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light and transmission electron microscopy of generalized dystrophic epidermolysis bullosa (Pasini's albopapuloid subtype).
    Almeida HL; Nudelmann L; Rocha NM; Castro LA
    An Bras Dermatol; 2012; 87(2):285-7. PubMed ID: 22570034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretibial epidermolysis bullosa: a clinicopathologic study.
    Lee JY; Chen HC; Lin SJ
    J Am Acad Dermatol; 1993 Dec; 29(6):974-81. PubMed ID: 8245264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosaminoglycans production by cultured skin fibroblasts from the Pasini and Cockayne-Touraine forms of dominant dystrophic epidermolysis bullosa.
    Priestley GC
    J Invest Dermatol; 1991 Feb; 96(2):168-71. PubMed ID: 1991977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression.
    McGrath JA; Ishida-Yamamoto A; O'Grady A; Leigh IM; Eady RA
    J Invest Dermatol; 1993 Apr; 100(4):366-72. PubMed ID: 8454899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TREATMENT OF EPIDERMOLYSIS BULLOSA DYSTROPHICA BY ALPHA TOCOPHEROL.
    WILSON HD
    Can Med Assoc J; 1964 Jun; 90(23):1315-6. PubMed ID: 14155127
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidermolysis bullosa controlled by vitamin E.
    Ayres S
    Int J Dermatol; 1986 Dec; 25(10):670-1. PubMed ID: 3804554
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group.
    Caldwell-Brown D; Stern RS; Lin AN; Carter DM
    N Engl J Med; 1992 Jul; 327(3):163-7. PubMed ID: 1608407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recessive dystrophic epidermolysis bullosa treated with phenytoin.
    Abahussein AA; al-Zayir AA; Mostafa WZ; Okoro AN
    Int J Dermatol; 1992 Oct; 31(10):730-2. PubMed ID: 1399206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic linkage between the collagen VII (COL7A1) gene and the autosomal dominant form of dystrophic epidermolysis bullosa in two Dutch kindreds.
    Gruis NA; Bavinck JN; Steijlen PM; van der Schroeff JG; van Haeringen A; Happle R; Mariman E; van Beersum SE; Uitto J; Vermeer BJ
    J Invest Dermatol; 1992 Nov; 99(5):528-30. PubMed ID: 1358979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Milia as an Isolated Skin Manifestation of Dominant Dystrophic Epidermolysis Bullosa: Evidence of Phenotypic Variability.
    Akasaka E; Nakano H; Takagi Y; Toyomaki Y; Sawamura D
    Pediatr Dermatol; 2017 Mar; 34(2):e106-e108. PubMed ID: 28008652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermolysis bullosa pruriginosa: A rare entity which responded well to thalidomide.
    Rani S; Gupta A; Bhardwaj M
    Dermatol Ther; 2019 Sep; 32(5):e13035. PubMed ID: 31355515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophic epidermolysis bullosa.
    Burkhart CG; Ruppert ES
    Clin Pediatr (Phila); 1981 Aug; 20(8):493-6. PubMed ID: 7249491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophic epidermolysis bullosa inversa: report of two cases with further correlation between electron microscopic and immunofluorescence studies.
    Lin AN; Smith LT; Fine JD
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 2):361-5. PubMed ID: 7615886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophic epidermolysis bullosa in goats.
    Medeiros GX; Riet-Correa F; Barros SS; Soares MP; Dantas AF; Galiza GJ; Simões SV; Borges AS
    J Comp Pathol; 2013 May; 148(4):354-60. PubMed ID: 23123123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Sporadic" dystrophic epidermolysis bullosa: a new dominant or mitis recessive mutation?
    Vaccaro M; Moretti G; Guarneri F; Cannavò S; Magaudda L
    Eur J Dermatol; 2000 Aug; 10(6):436-8. PubMed ID: 10980463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Dominant Dystrophic Epidermolysis Bullosa Responding Well to an Old Medication.
    Leung J; Kuzel P; Kurian A; Brassard A
    JAMA Dermatol; 2015 Nov; 151(11):1264-5. PubMed ID: 26154424
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neonatal hereditary dystrophic epidermolysis bullosa: a genetically diagnosed case report].
    Jiang Y; Hou XL; Li X; Lin ZS; Cui C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):202-6. PubMed ID: 23591337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.